Standard

Medication use (antiglaucoma preparations and miotics)

PNPT1 · rs706550

Where this position leads

Condition: Glaucoma

rs706550 Condition: Glaucoma Glaucoma Condition rs706550 rs706550 PNPT1

What each result means

A/A Published research associates this genotype (two copies of the reported risk allele) with a higher likelihood of Medication use (antiglaucoma preparations and miotics) compared to the general population. (GWAS Catalog, Nat Commun 2019, PMID:31015401)
A/G Published research associates this genotype (one copy of the reported risk allele) with an intermediate association with Medication use (antiglaucoma preparations and miotics). (GWAS Catalog, Nat Commun 2019, PMID:31015401)
G/G Published research associates this genotype with typical/baseline likelihood of Medication use (antiglaucoma preparations and miotics) — no copies of the reported risk allele. (GWAS Catalog, Nat Commun 2019, PMID:31015401)

Source: GWAS Catalog, Nat Commun 2019, PMID:31015401

Questions about rs706550

What is rs706550?

rs706550 is a single position in the genome, in or near the PNPT1 gene. Published research associates it with medication use (antiglaucoma preparations and miotics). A single variant does not decide an outcome — it shifts a probability, and for most common variants the shift is small.

What conditions is rs706550 linked to?

On MyGeneLog this position is linked to Glaucoma. The research behind each link, and its sources, are set out on that condition page.

Does having rs706550 mean I will get this?

No. Common variants like this one move a probability slightly and, on their own, rarely decide anything about one person. Nothing on this page is a diagnosis, and health decisions should be made with a clinician who can see your whole picture.

Where does the information about rs706550 come from?

GWAS Catalog, Nat Commun 2019, PMID:31015401. Every variant on MyGeneLog comes from public primary sources and is published with its citation and the date it was checked.

← See all variants